DOCSLIB.ORG

Esther M. Sternberg, MD

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Esther M. Sternberg, MD CURRICULUM VITAE Esther M. Sternberg, MD Chronology of Education McGill University, Montreal, Quebec, Canada 05/1972 B.Sc., with Great Distinction McGill University, Montreal, Canada 05/1974 M.D.C.M. Licensure Licentiate, Medical Council of Canada (LMCC) 1975 Permit to Practice Medicine, Province of Quebec, Canada 1975 Missouri Medical License (renewable annually) 12/1981 - present Board Certifications Diploma, National Board of Medical Examiners, USA 1977 Royal College of Physicians and Surgeons of Canada examinations in Internal Medicine (written section) 1978 Royal College of Physicians and Surgeons of Canada examinations in Rheumatology (written section) 1980 Specialist Certification in Rheumatology Quebec Corporation of Physicians and Surgeons 12/1980 Chronology of Employment Intern, Medicine 07/1974-06/1975 McGill University, Royal Victoria Hospital, Montreal, Canada General Practice 1975-06/1977 Town of Mount Royal, Quebec, Canada Resident II, Medicine 07/1977-06/1978 McGill University, Royal Victoria Hospital, Montreal, Canada Clinical Fellow, Rheumatology 07/1978-06/1979 McGill University, Royal Victoria Hospital, Montreal, Canada Clinical and Research Fellow, Rheumatology 07/1979-10/1980 McGill University, Royal Victoria Hospital, Montreal, Canada Research Associate 04/1981-1983 Division of Allergy and Clinical Immunology, Department of Medicine Washington University School of Medicine, St. Louis, MO Esther M. Sternberg, MD Page 2 of 52 upated October 2013 Research Associate 1983-1984 Division of Allergy and Clinical Immunology, Department of Internal Medicine Howard Hughes Medical Institute Washington University School of Medicine, St. Louis, MO Associate Howard Hughes Medical Institute 1984-12/1986 Washington University, School of Medicine, St. Louis, MO Instructor 1984-12/1986 Division of Rheumatology, Department of Medicine Washington University School of Medicine, St. Louis, MO Attending Physician 1984-12/1986 Barnes Hospital, St. Louis, MO Visiting Scientist 12/1986-1990 National Institute of Arthritis, Musculoskeletal and Skin Diseases (NIAMS) NIH, Bethesda, MD Guest Researcher 12/1986-1990 Clinical Neurosciences Branch National Institute of Mental Health (NIMH) Alcohol, Drug Abuse & Mental Health Agency (ADAMHA), Bethesda, MD Visiting Scientist 1989-1990 NIAMS, NIH Head, Inter-Institute Unit on Neuroendocrine Immunology and Behavior, NIMH and National Institute of Arthritis, Musculoskeletal and Skin Diseases (NIAMS) NIH and ADAMHA, Bethesda, MD Tenured senior scientist 1991- 2012 NIMH, NIH, Bethesda, MD Medical Officer and Chief 1991-1995 Unit on Neuroendocrine Immunology and Behavior, Clinical Neuroendocrinology Branch NIMH, NIH, Bethesda, MD Associate Branch Chief 1994-1999 Clinical Neuroendocrinology Branch NIMH, NIH, Bethesda, MD Medical Officer and Chief 1995-2012 Section on Neuroendocrine Immunology and Behavior NIMH, NIH, Bethesda, MD Research Full Professor 1995-2012 Dept. Psychology, School Arts & Sciences American University, Washington, DC Director 1999-2000 NIMH Intramural Integrative Molecular, Cellular and Behavioral Neuroscience Program Esther M. Sternberg, MD Page 3 of 52 upated October 2013 NIMH, NIH, Bethesda, MD Director 2000-2012 NIMH Intramural Integrative Neural Immune Program NIMH, NIH, Bethesda, MD Co-Chair 2002-2012 Intramural Program on Research on Women’s Health, (IPRWH), Office of Intramural Research and ORWH, Office of Director (OD) NIH, Bethesda, MD Senior Tenured Scientist, NIH (retired) 2012-present Special Volunteer, NIMH/NIH 2012-2013 University of Arizona 2012-present Tucson, AZ Research Director Center for Integrative Medicine Director Institute on Place and Wellbeing Professor of Medicine College of Medicine Honors and Awards 1967-1968 McGill University Entrance Scholarship 1968-1971 McGill University Scholarships 1970 McGill University Delegate, Voyage d'Observation et d’Information en France, May-June 1979-1980 Royal Victoria Hospital (McGill University) Research and Development Fund Award 1979-1983 Fellow of the Canadian Arthritis Society 1982 American Academy of Allergy/Schering Travel Grant Award, March 1987-1990 Visiting Scientist, National Institute of Arthritis, Musculoskeletal and Skin Diseases (NIAMS), NIH, Bethesda, MD 1987-1990 Guest Researcher Clinical, Neurosciences Branch National Institute of Mental Health (NIMH) ADAMHA, Bethesda, MD 1989-1990 Visiting Scientist , NIAMS, NIH Head, Inter-Institute Unit on Neuroendocrine Immunology and Behavior, NIMH and National Institute of Arthritis, Musculoskeletal and Skin Diseases (NIAMS), NIH and ADAMHA, Bethesda,MD 1991 Arthritis Foundation, Metropolitan Washington Chapter, William R. Felts Award for excellence in Rheumatology Research Publications 1991 Food and Drug Administration Commissioner's Special Citation for Outstanding Contributions in the Study of the Etiology of Eosinophilia -Myalgia Syndrome. Esther M. Sternberg, MD Page 4 of 52 upated October 2013 1994 Public Health Service Superior Service Award for identifying the pathogenesis of the L-Tryptophan Eosinophilia Myalgia Syndrome and elucidating a critical role for the central nervous system in conferring susceptibility to inflammatory disease 1995 Member, John D. and Catherine T. MacArthur Foundation, Network on Mind-Body Interactions 1995-present American Society for Clinical Investigation, elected member 1995 National Library of Medicine representative to National Academy of Sciences' and Institute of Medicine's Presidents' Circle Tour of the National Library of Medicine and Emotions and Disease Exhibition 1996-97 Co-Director, National Library of Medicine Exhibition on Emotions and Disease, National Library of Medicine, Bethesda, MD 1998 J.F.L. Woodbury Lectureship in Rheumatology, Dalhousie University, Halifax, Canada 1998-2006 Member, Committee on Military Nutrition Research, Institute of Medicine, National Academy of Sciences 1999 United States Department of Health and Human Services Public Health Service Staff Recognition Award, in Recognition and Appreciation of Special Achievement 2000 Elected member, Cosmos Club of Washington DC 2000 Publisher Nominated for Pulitzer Prize for “The Balance Within. The Science Connecting Health and Emotions.” W.H. Freeman & Co, 2000 2000 United States Department of Health and Human Services Public Health Staff Recognition Award 2001 United States Department of Health and Human Services Public Health Special Act or Service Award, in Recognition and Appreciation of Special Achievement 2002 United States Department of Health and Human Services Public Health, National Institutes of Health, NIMH Director’s Merit Award for Leadership in Developing Interdisciplinary Programs 2003-2005 One of 300 women physicians honored in National Library of Medicine Exhibition celebrating 150 years of women in medicine: “Changing the Face of Medicine: Celebrating America’s Women Physicians” 2003 Distinguished Visiting Professor, Singapore A*STAR/BMRC 2003 Lecturer, Nobel Forum on Gender Medicine, Karolinska Institute, Stockholm 2003 Trans NIH NIAID Intramural Biodefense Program Award 2003-2005 2004 Honorary Host, opening Sister-to-Sister Women’s Heart Health Event, Madison Square Garden, NY, NY 2005 Keynote Lecture, Royal Society of Medicine, London, UK 2005 Moderator & Panelist, with XIVth Dalai Lama. Stress & Health Panels, Mind and Life Institute, Society for Neuroscience Satellite 2006 Trans NIH/FDA Intramural Biodefense Program Award 2006-2008 2006 George O’Brien Lecture, Harvard Children’s Hospital, Boston MA 2006 Personal Health Panel Co-Chair, Fortune Most Powerful Women Summit 2006 Society for Neuroscience, President’s Panel, Frank Gehry Science & Society lecture, Architecture & the Brain 2006 “Leader in Neuroscience”, Frank Gehry Science & Society lecture, Architecture & the Brain 2007 Keynote Lecture. Harvard/Dana Alliance Conference on Learning and the Brain Conference. Boston, MA 2007 John J. Conley Lecturer. American Association for Facial Plastic & Reconstructive Surgery. Washington, DC Esther M. Sternberg, MD Page 5 of 52 upated October 2013 2007 Moderator, Press Conference “The New Neuroimmunology”, Society for Neuroscience, San Diego, CA 2007 Health Panel, Governor of Pennsylvania's Conference on Women, Philadelphia, PA 2007 Keynote Address. Brain Immune Interactions: Science of the Mind Body Connection. Johns Hopkins/Healthways Health Outcomes Summit, Austin, TX 2007 Honored at University of Maryland (Baltimore), Opening of National Library of Medicine’s “Changing the Face of Medicine: Celebrating America’s Women Physicians” Traveling Exhibition 2008 Panelist, United Nations September 11 Symposium “Beyond the Mind Body Problem.” Sept. 11, 2008 2009 Institute of Medicine Summit on Integrative Medicine, Organizing Committee & Panelist, Washington, DC, Feb. 2009 2009 Host and creator, PBS Television Special “The Science of Healing with Dr. Esther Sternberg” 2009 Sunday Forum Special Guest, Washington National Cathedral, Washington, D.C., Nov. 2009 2009-2012 Dept. of Defense/USUHS Center for Neuroscience & Regenerative Medicine (CNRM) Award 2009-2010 NIH Director’s Challenge Award 2009-2010 2010 October 2010 Community Ambassador Award, Donna Karan Urban Zen Foundation, New York, NY 2010 Australian Arts and Health Foundation Keynote Speaker & Distinguished Visiting Professor, Brisbane, Newcastle, Melbourne, Adelaide & Sydney, Australia, Oct. 2010 2010 Keynote Address, Center for Health Design National Conference, Las Vegas, NV Nov. 2010 2010 Science of Healing Screening and Panel Discussion with Dr. Andrew Weil,
Load more

Recommended publications
  • Focal Eosinophilic Myositis Presenting with Leg Pain and Tenderness
    CASE REPORT Ann Clin Neurophysiol 2020;22(2):125-128 https://doi.org/10.14253/acn.2020.22.2.125 ANNALS OF CLINICAL NEUROPHYSIOLOGY Focal eosinophilic myositis presenting with leg pain and tenderness Jin-Hong Shin1,2, Dae-Seong Kim1,2 1Department of Neurology, Research Institute for Convergence of Biomedical Research, Pusan National University Yangsan Hospital, Yangsan, Korea 2Department of Neurology, Pusan National University School of Medicine, Yangsan, Korea Focal eosinophilic myositis (FEM) is the most limited form of eosinophilic myositis that com- Received: September 11, 2020 monly affects the muscles of the lower leg without systemic manifestations. We report a Revised: September 29, 2020 patient with FEM who was studied by magnetic resonance imaging and muscle biopsy with Accepted: September 29, 2020 a review of the literature. Key words: Myositis; Eosinophils; Magnetic resonance imaging Correspondence to Dae-Seong Kim Eosinophilic myositis (EM) is defined as a group of idiopathic inflammatory myopathies Department of Neurology, Pusan National associated with peripheral and/or intramuscular eosinophilia.1 Focal eosinophilic myositis Univeristy School of Medicine, 20 Geu- mo-ro, Mulgeum-eup, Yangsan 50612, (FEM) is the most limited form of EM and is considered a benign disorder without systemic 2 Korea manifestations. Here, we report a patient with localized leg pain and tenderness who was Tel: +82-55-360-2450 diagnosed as FEM based on laboratory findings, magnetic resonance imaging (MRI), and Fax: +82-55-360-2152 muscle biopsy. E-mail: [email protected] ORCID CASE Jin-Hong Shin https://orcid.org/0000-0002-5174-286X A 26-year-old otherwise healthy man visited our outpatient clinic with leg pain for Dae-Seong Kim 3 months.
    [Show full text]
  • A Acanthosis Nigricans, 139 Acquired Ichthyosis, 53, 126, 127, 159 Acute
    Index A Anti-EJ, 213, 214, 216 Acanthosis nigricans, 139 Anti-Ferc, 217 Acquired ichthyosis, 53, 126, 127, 159 Antigliadin antibodies, 336 Acute interstitial pneumonia (AIP), 79, 81 Antihistamines, 324 Adenocarcinoma, 115, 116, 151, 173 Anti-histidyl-tRNA-synthetase antibody Adenosine triphosphate (ATP), 229 (Anti-Jo-1), 6, 14, 140, 166, 183, Adhesion molecules, 225–226 213–216 Adrenal gland carcinoma, 115 Anti-histone antibodies (AHA), 174, 217 Age, 30–32, 157–159 Anti-Jo-1 antibody syndrome, 34, 129 Alanine aminotransferase (ALT, ALAT), 16, Anti-Ki-67 antibody, 247 128, 205, 207, 255 Anti-KJ antibodies, 216–217 Alanyl-tRNA synthetase, 216 Anti-KS, 82 Aldolase, 14, 16, 128, 129, 205, 207, 255, 257 Anti-Ku antibodies, 163, 165, 217 Aledronate, 325 Anti-Mas, 217 Algorithm, 256, 259 Anti-Mi-2 Allergic contact dermatitis, 261 antibody syndrome, 11, 129, 215 Alopecia, 62, 199, 290 antibodies, 6, 15, 129, 142, 212 Aluminum hydroxide, 325, 326 Anti-Myo 22/25 antibodies, 217 Alzheimer’s disease-related proteins, 190 Anti-Myosin scintigraphy, 230 Aminoacyl-tRNA synthetases, 151, 166, 182, Antineoplastic agents, 172 212, 215 Antineoplastic medicines, 169 Aminoquinolone antimalarials, 309–310, 323 Antinuclear antibody (ANA), 1, 141, 152, 171, Amyloid, 188–190 172, 174, 213, 217 Amyopathic DM, 6, 9, 29–30, 32–33, 36, 104, Anti-OJ, 213–214, 216 116, 117, 147–153 Anti-p155, 214–215 Amyotrophic lateral sclerosis, 263 Antiphospholipid syndrome (APS), 127, Antisynthetase syndrome, 11, 33–34, 81 130, 219 Anaphylaxi, 316 Anti-PL-7 antibody, 82, 214 Anasarca,
    [Show full text]
  • Muscle Biopsy Features of Idiopathic Inflammatory Myopathies And
    Autoimmun Highlights (2014) 5:77–85 DOI 10.1007/s13317-014-0062-2 REVIEW ARTICLE Muscle biopsy features of idiopathic inflammatory myopathies and differential diagnosis Gaetano Vattemi • Massimiliano Mirabella • Valeria Guglielmi • Matteo Lucchini • Giuliano Tomelleri • Anna Ghirardello • Andrea Doria Received: 1 August 2014 / Accepted: 22 August 2014 / Published online: 10 September 2014 Ó Springer International Publishing Switzerland 2014 Abstract The gold standard to characterize idiopathic Keywords Inflammatory myopathy Á Autoimmune inflammatory myopathies is the morphological, immuno- myositis Á Histopathology Á Differential diagnosis histochemical and immunopathological analysis of muscle biopsy. Mononuclear cell infiltrates and muscle fiber necrosis are commonly shared histopathological features. Introduction Inflammatory cells that surround, invade and destroy healthy muscle fibers expressing MHC class I antigen are Idiopathic inflammatory myopathies (IIM) are a heteroge- the typical pathological finding of polymyositis. Perifas- neous group of acquired muscle diseases, which have dis- cicular atrophy and microangiopathy strongly support a tinct clinical, pathological and histological features [1, 2]. diagnosis of dermatomyositis. Randomly distributed The most common IIM seen in clinical practice can be necrotic muscle fibers without mononuclear cell infiltrates separated into four categories including polymyositis (PM), represent the histopathological hallmark of immune-med- dermatomyositis (DM), immune-mediated necrotizing iated necrotizing myopathy; meanwhile, endomysial myopathy (NM) and sporadic inclusion body myositis inflammation and muscle fiber degeneration are the two (sIBM) [1, 3]. main pathological features in sporadic inclusion body In the diagnostic workup of an inflammatory myopathy, myositis. A correct differential diagnosis requires immu- muscle biopsy is an indispensable and sensitive tool for nopathological analysis of the muscle biopsy and has establishing the diagnosis.
    [Show full text]
  • NEUROLOGY NEUROSURGERY & PSYCHIATRY Editorial
    Journal ofNeurology, Neurosurgery, and Psychiatry 1991;54:285-287 285 J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.54.4.285 on 1 April 1991. Downloaded from Joural of NEUROLOGY NEUROSURGERY & PSYCHIATRY Editorial The idiopathic inflammatory myopathies and their treatment The inflammatory myopathies are the largest group of As new knowledge has accumulated over the course of acquired myopathies of adult life and may also occur in the last 10 years, it has become increasingly clear that there infancy and childhood. They have in common the presence are distinct pathological and immunological differences of inflammatory infiltrates within skeletal muscle, usually between polymyositis on the one hand and dermato- in association with muscle fibre destruction. They can be myositis on the other, though in some cases there is clearly subdivided into those which are due to known viral, an overlap between the two conditions. In polymyositis bacterial, protozoal or other microbial agents and those in there is usually scattered necrosis of single muscle fibres which no such agent can be identified and in which which appear hyalinised in the early stages and are immunological mechanisms have been implicated.' The subsequently invaded by mononuclear phagocytic cells. latter group includes polymyositis, dermatomyositis and Regenerating fibres are usually seen singly or in small inclusion body myositis. The evidence for an autoimmune groups distributed focally and randomly throughout the aetiology consists of: 1) an association with other auto- muscle. The inflammatory cell infiltrate is predominantly immune diseases; 2) serological tests which reflect an intrafascicular (endomysial) surrounding muscle fibres altered immune state; and 3) the responsiveness of rather than in the interfascicular septa, though perivascular polymyositis and dermatomyositis, if not of the inclusion infiltrates may also be found; the cellular infiltrate consists body variety, to immunotherapy.2 Polymyositis may rarely mainly of lymphocytes, plasma cells and macrophages.
    [Show full text]
  • Connective Tissue 5.2.04
    Other Connective Tissue Diseases Chester V. Oddis, MD Thomas A. Medsger, Jr, MD Arthur Weinstein, MD Contents 1. Undifferentiated Connective Tissue Disease 2. Idiopathic Inflammatory Myopathy 3. Scleroderma 4. Sjögren’s Syndrome 5. References OTHER CONNECTIVE TISSUE DISEASES 1 1. Undifferentiated Connective Tissue Disease Table 1 The American College of Rheumatology (ACR) has published criteria for several different diseases Clinical Features and Autoantibody Findings commonly referred to as connective tissue disease Possibly Specific for a Defined CTD (CTD). The primary aim of such classification crite - ria is to ensure the comparability among CTD stud - ies in the scientific community. These diseases Clinical Feature include rheumatoid arthritis (RA), systemic sclero - sis (SSc), systemic lupus erythematosus (SLE), Malar rash polymyositis (PM), dermatomyositis (DM), and Sjögren’s syndrome (SS). These are systemic Subacute cutaneous lupus rheumatic diseases which reflects their inflamma - tory nature and protean clinical manifestations with Sclerodermatous skin changes resultant tissue injury. Although there are unifying immunologic features that pathogenetically tie Heliotrope rash these separate CTDs to each other, the individual disorders often remain clinically and even serologi - Gottron’s papules cally distinct. Immunogenetic data and autoanti - body findings in the different CTDs lend further Erosive arthritis support for their distinctive identity and often serves to subset the individual CTD even further, as seen with the myositis syndromes, SLE and SSc. In other cases, it remains difficult to classify individuals Autoantibody with a combination of signs, symptoms, and labora - tory test results. It is this group of patients that have Anti-dsDNA an “undifferentiated” connective tissue disease (UCTD), or perhaps more accurately, an undifferen - Anti-Sm tiated systemic rheumatic disease.
    [Show full text]
  • The Editors of the Journal Ofclinical Investigation Gratefully
    The Editors ofThe Journal ofClinical Investigation gratefully acknowledge the assistance ofthefollowing reviewers who served during the periodfrom 1 August 1989 through 31 July 1990. Stuart Aaronson Gordon Amidon Lloyd Axelrod Daniel Beauchamp Nanette H. Paul Bormstein Francois M. Claude Amiel Ole Baadsgaard Arthur Beaudet Bishopric Gerry R. Boss Abboud Arthur J. Ammann Bernard M. Babior Daniel Bechard D. Montgomery G. F. Bottazzo Hanna E. Abboud Helmut V. Ammon Robert J. Bache Lewis C. Becker Bissell Elias H. Botvinick George Abela Athanasius Bruce R. Bacon Richard Behringer Mina J. Bissell Claude Bouchard Dana R. Anagnostou David Bader David A. Bell Peter Bitterman Richard C. Abendschein Clark L. Anderson Kamal F. Badr Graeme I. Bell Ingemar Bjorkhem Boucher J. A. Abildskov Donald C. Steinun Norman H. Bell Robert E. Black Andrew J. M. Janis Abkowitz Anderson Baekkeskov William R. Bell William G. Boulton Robert T. Abraham Jeffrey L. Anderson Jacques U. Joseph A. Bellanti Blackard Bonno N. Bouma Dale R. Robert J. Anderson Baenziger Sam Benchimol George L. Daniel Bowen- Abrahamson Sharon Anderson Grover C. Bagby Earl P. Benditt Blackburn Pope Donald I. Abrams Giuseppe Andres Marco Baggiolini William E. Benitz Perry Blackshear Laurence Boxer Christine Abrass Reubin Andres Corrado Baglioni Joel S. Bennett Paul Blake Linda Boxer Naji N. Abumrad Aubie Angel Andrew D. Baines John E. Bennett J. Edwin Blalock Aubrey E. Boyd Hugh Ackerman Harry N. Dorothy Bainton Michael Bennett Rebecca Blanton James L. Boyer Steven Ackerman Antoniades Andrew Baird Vann Bennett Roland C. Blantz Thomas Boyer Brian A. Ackrell Asok C. Antony Robert S. Balaban Neal L. Benowitz Terrence F.
    [Show full text]
  • Pathological Evaluation of Probiotic, Bacillus Subtilis, Against
    Journal of American Science, 2011; 7(2) http://www.americanscience.org Pathological Evaluation of Probiotic, Bacillus Subtilis, against Flavobacterium columnare in Tilapia Nilotica (Oreochromis Niloticus) Fish in Sharkia Governorate, Egypt Mohamed H Mohamed and Nahla AG Ahmed Refat Dept of Vet. Pathology, Fac Vet Medicine, Zagazig University, 44519 Zagazig City, Egypt. Nahla_kashmery@hotmail [email protected] Abstract: Fifteen out-of eighty-five of collected Tilapia nilotica fish (17.64%) showing skin lesions, were positive for Flavobacterium columnare with cultural, morphological and biochemical characteristics. These skin lesions were large erosions with loss of scales and red-grayish patches, particularly at the frontal head region and abdomen. All of the positive isolates (Flavobacterium columnare) were molecularly tested by means of PCR. With consistent with F. columnare standard ATCC 49512 strain, these isolates produced a 675 bp band. One hundred apparently healthy Tilapia nilotica fingerlings (30±5 gm) were used to evaluate the effectiveness of probiotic, Bacillus subtilis, in water or diet against the intramuscular challenge with Flavobacterium columnare infection. They were equally divided into 10 groups (10 fish for each group). Five groups were experimental control {placebo (gp 1), intramuscularly infected with 0.2 x108 F. columnare CFU (gp 2), received 0.1 gm/L probiotic in water (gp 3), 0.2 gm /L probiotic in fish diet (gp 4), or 1 gm/L oxytetracycline (gp 5)}; two were prophylactic experiment {received 0.1 (gp 6) or 0.2 (gp 7) gm of probiotic in water and diet, respectively 2 months before bacterial infection and continued for a week later}; and three were treated experiment {intramuscularly infected with 0.2 x108 F.
    [Show full text]
  • UNIVERSITY of CALIFORNIA Los Angeles Eosinophil Infiltration In
    UNIVERSITY OF CALIFORNIA Los Angeles Eosinophil Infiltration in Muscular Dystrophy: Key Characteristics and Contributions to Disease A dissertation submitted in partial satisfaction of the requirements for the degree Doctor of Philosophy in Molecular, Cellular & Integrative Physiology by Albert Chi Sek 2020 © Copyright by Albert Chi Sek 2020 ABSTRACT OF THE DISSERTATION Eosinophil Infiltration in Muscular Dystrophy: Key Characteristics and Contributions to Disease By Albert Chi Sek Doctor of Philosophy in Molecular, Cellular & Integrative Physiology University of California, Los Angeles, 2020 Professor Tomas Ganz, Chair Duchenne Muscular Dystrophy (DMD) is a genetic disorder that affects 1 in 3,500 live male births. In DMD patients, inactivating mutations in the gene encoding dystrophin prevent expression of this critical cytoskeletal protein that is essential for myofiber integrity. Mutations in the gene encoding dystrophin have also been detected in muscular dystrophy (mdx) mice, which phenocopy the disease seen in DMD patients. As a result of dystrophin deficiency, the skeletal and cardiac muscles undergo severe degeneration accompanied by infiltration with inflammatory cells. Eosinophils are prominent among the leukocytes recruited to dystrophin-deficient skeletal muscle tissues, although their contributions to disease are incompletely understood. Eosinophils are capable of releasing cytotoxic mediators stored in cytoplasmic granules; as such, eosinophils have been viewed largely as mediators of tissue destruction. I began this work with an evaluation of the extent and impact of eosinophil infiltration on acute muscle damage in muscular dystrophy mice. Towards this end, I generated eosinophil-deficient (mdx.PHIL) and eosinophil-overabundant (mdx.IL5tg) strains of mdx mice. Despite the varied levels of eosinophil ii infiltration detected in skeletal muscle tissues, my studies revealed that there were remarkably similar levels of muscle damage in mdx, mdx.IL5tg and mdx.PHIL mice.
    [Show full text]
  • Focal Eosinophilic Myositis Associated with Behçet's Disease
    pISSN: 2093-940X, eISSN: 2233-4718 Journal of Rheumatic Diseases Vol. 24, No. 5, October, 2017 https://doi.org/10.4078/jrd.2017.24.5.303 Case Report Focal Eosinophilic Myositis Associated with Behçet's Disease Jung Su Eun1, Jong Wan Kang1, Jin Young Kang2, Na Ri Kim1, Sang Jin Lee1, Young Mo Kang1, Man Hoon Han3, Eon Jeong Nam1 1Division of Rheumatology, Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, 2Division of Rheumatology, Department of Internal Medicine, Changwon Fatima Hospital, Changwon, 3Department of Pathology, Kyungpook National University School of Medicine, Daegu, Korea Behçet’s disease (BD) is a systemic vasculitis commonly accompanied by recurrent mucosal ulceration and other systemic man- ifestations, but rarely by myositis. Focal eosinophilic myositis is the most limited idiopathic eosinophilic myopathy charac- terized by peripheral blood eosinophilia and/or eosinophilic muscle infiltration. Clinical manifestations include myalgia, mus- cle weakness, and cutaneous lesions, such as subcutaneous induration and erythema. Given that BD can mimic deep vein thrombosis or pseudotumor, muscle biopsy should be performed to enhance the accuracy of diagnosis. Microscopic examina- tion reveals extensive infiltration of eosinophils and mononuclear cells into muscle, myofiber necrosis, and regeneration. To the best of our knowledge, there have not been any published reports on MEDLINE regarding focal eosinophilic myositis asso- ciated with BD. Here, we presented a case of focal eosinophilic myositis associated with intestinal BD in a 23-year-old man who suffered from a large ulcer in the terminal ileum. (J Rheum Dis 2017;24:303-308) Key Words. Behçet’s disease, Idiopathic eosinophilic myopathy, Focal eosinophilic myositis INTRODUCTION ositis [1,6].
    [Show full text]
  • Systemic Granulomatosis in Guppies Poecilia Reticulata
    Kasetsart J. (Nat. Sci.) 35 : 456 - 459 (2001) Systemic Granulomatosis in Guppies Poecilia reticulata Nontawith Areechon1, Nantarika Chansue2, Aranya Ponpornpisit2, Terutoyo Yoshida3 and Makoto Endo3 ABSTRACT In many guppy Poecilia reticulata farms in the vicinity of Bangkok, diseases have caused long- lasting fish death and consequently large cumulative mortality. Diseased guppies were collected and subjected to histopathological analysis. The analysis revealed systemic granulomatosis as a remarkable histological sign. Rod-shaped bacterial cells with strong acid-fastness were found in the granulomas. Therefore, this disease was diagnosed as acid-fastness bacterial infection. The acid-fastness bacterium infection seems to predispose various infections in the critical stage of the disease. Key words: guppy, granuloma, acid-fastness bacterium, histopathology INTRODUCTION and marketing processes. The pathogenic bacteria like Aeromonas hydrophila and Flexibacter Ornamental fish business has slowly but columnaris and protozoan Tetrahymena and steadily grown up and become an industry in Epistylis are isolated from the diseased fish in most Thailand. Many species are being spawned and cases. However, the treatments usually end up in raised in commercial scale in farms all around the unsuccessful result where mortality continues country such as Siamese fighting fish, goldfish and causing severe loss in each crop. This discus. Harvests are distributed within the country histopathological study revealed the systemic and many species are highly demanded from many granulomatosis as a remarkable histological sign countries all around the world. Guppy Poecilia from the diseased guppies. Suggestion on the reticulata is the most popular fish on the commercial etiology and control method of this disease was also basis farming nation-wide.
    [Show full text]
  • B Disorders of Autonomic Nervous System
    Application of the International Classification of Diseases to Neurology \ Second Edition World Health Organization Geneva 1997 First edition 1987 Second edition 1997 Application of the international classification of diseases to neurology: ICD-NA- 2nd ed. 1. Neurology - classification 2. Nervous system diseases - classification I. Title: ICD-NA ISBN 92 4 154502 X (NLM Classification: WL 15) The World Health Organization welcomes requests for permission to reproduce or translate its publications, in part or in full. Applications and enquiries should be addressed to the Office of Publications, World Health Organization, Geneva, Switzerland, which will be glad to provide the latest information on any changes made to the text, plans for new editions, and reprints and translations already available. ©World Health Organization 1997 Publications of the World Health Organization enjoy copyright protection in accordance with the provisions of Protocol 2 of the Universal Copyright Convention. All rights reserved. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of
    [Show full text]
  • Pathology of Eosinophilic Fasciitis and Its Relation to Polymyositis Ke-Wei Huang and Xiao-Han Chen
    THE CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES Pathology of Eosinophilic Fasciitis and its Relation to Polymyositis Ke-Wei Huang and Xiao-Han Chen ABSTRACT: The anatomical substrate of eosinophilic fasciitis (EF) was studied in 15 muscle biopsy specimens of this disease, six of which included the dermis and subcutaneous tissue. As controls, 94 postmortem muscle specimens from patients dying of non-muscular diseases were used. Of these 94 specimens, 22 (23.4%) showed practically no deep fascia and 72 specimens showed a single dense bundle of collagen with no distinction between deep fascia and epimysium. The 15 specimens of EF showed thickening and inflammatory infiltration of varying degrees in the deep fascia, epimysium, perimysium, endomysium and also in muscle. We conclude that the anatomical substrate of EF is not confined to the deep fascia, but involves other structures including mysia and muscle itself. Most reported cases of EF in the literature do not even describe muscle. A comparative study of 15 biopsy specimens of polymyositis and dermatomyositis with those of EF revealed only quantitative differences in the histopathological changes of muscle and mysia, inflammatory infiltrate and eosinophilia. We suggest that the diseases are more closely related than previously recognized. RESUME: L'anatomo-pathologie de la fasciite a eosinophils et sa relation avec la polymyosite. Quinze specimens anatomo-pathologiques obtenus par biopsies musculaires chez des sujets atteints de fasciite a eosinophils (FE) ont e;t6 etudies. Six de ces specimens comprenaient le derme et du tissu sous-cutane. Quatre-vingt-quatorze specimens de muscle obtenus a partir de materiel d'autopsie provenant de patients d^cedes de maladies autres que de maladies musculaires ont 6t6 utilises comme controles.
    [Show full text]